A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors

A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors

Glioblastoma (GBM) is the most common and aggressive form of malignant glioma in adults with a median overall survival (OS) time of 16–18 months and a median age of diagnosis at 64 years old. Recent work has suggested that depression and psychosocial distress are associated with worse outcomes in pa...

Full description

Bibliographic Details
Main Authors: Sebastian Otto-Meyer, Rian DeFaccio, Corey Dussold, Erik Ladomersky, Lijie Zhai, Kristen L. Lauing, Lakshmi R. Bollu, Christina Amidei, Rimas V. Lukas, Denise M. Scholtens, Derek A. Wainwright
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:Brain, Behavior, & Immunity - Health
Subjects:
Psychosocial
Biobehavioral
Glioma
Depression
Antidepressant
Immunosuppression
Online Access:http://www.sciencedirect.com/science/article/pii/S2666354619300250

Internet

http://www.sciencedirect.com/science/article/pii/S2666354619300250

Similar Items